ロード中...
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
OBJECTIVE: Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ketoacidosis (euDKA) in hopes that it will enhance recognition of this potentially life-threatening complicatio...
保存先:
| 出版年: | Diabetes Care |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Diabetes Association
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4542270/ https://ncbi.nlm.nih.gov/pubmed/26078479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc15-0843 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|